http://orcid.org/0000-0002-5953-3704
References
- Thompson MM, Hassoun A. Successful salvage treatment of native valve Enterococcus faecalis infective endocarditis with telavancin: two case reports. Infect Dis (Lond). 2017;49(7):540–544.
- Miro JM, Pericas JM, del Rio A. A new era for treating Enterococcus faecalis endocarditis: ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question! Circulation. 2013;127(17):1763–1766.
- Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.
- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128.
- Beganovic M, Luther MK, Rice LB, et al. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis. 2018;67(2):303–309.
- Maher M, Jensen KJ, Lee D, et al. Stability of ampicillin in normal saline and buffered normal saline. Int J Pharm Compd. 2016;20(4):338–342.
- Gil-Navarro MV, Lopez-Cortes LE, Luque-Marquez R, et al. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis. J Clin Pharm Ther. 2018;43(2):220–223.
- Kim D, Lee H, Yoon EJ, Hong JS, et al. Prospective observational study of the clinical prognoses of patients with bloodstream infections caused by ampicillin-susceptible but penicillin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 2019;63(7):e00291–19.
- Mainardi JL, Gutmann L, Acar JF, et al. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother. 1995;39(9):1984–1987.
- Tritle BJ, Timbrook TT, Fisher MA, et al. Penicillin as a potential agent for dual beta-lactam therapy for enterococcal endocarditis. Clin Infect Dis. 2019:ciz594. DOI:10.1093/cid/ciz594.